In a thought-provoking discussion on the Huberman Lab podcast, renowned functional medicine expert Dr. Mark Hyman made a bold statement regarding the increasingly popular GLP-1 agonist medications like Ozempic, suggesting that prescribing these types of things without proper exercise and nutritional guidance is problematic.
“I personally think it should be illegal to prescribe these dr*gs unless they’re combined with a nutrition consult to educate people about their protein requirements that are increased and with an exercise or a trainer physiologist or trainer to help them develop a strength training program,” Dr. Hyman stated during his conversation with Stanford neuroscientist Dr. Andrew Huberman.
Dr. Hyman expressed concern about the muscle loss that commonly occurs with these medications. When patients lose weight on GLP-1 agonists, they often lose both fat and muscle mass, which can significantly impact their metabolism long-term.
“You lose the weight and you lose muscle and fat and if you lose half it is muscle then your metabolism slows down because muscle burns seven times as much calories as fat,” he explained. This metabolic downshift becomes particularly problematic if patients discontinue the medication, as Dr. Hyman noted that “over 65% of people” who stop taking these dr*gs regain the weight.
The metabolic consequences can be severe: “When you gain the weight back if you stop… they just start eating more again and they have lower muscle mass and then you’re in a worse situation because you have a lower muscle mass. So you could eat literally the same amount of calories as you were before you lost weight and gain weight because your metabolism is messed up.”
While acknowledging that GLP-1 agonists can be effective tools for weight management, Dr. Hyman emphasized they should be part of a comprehensive approach: “Can they be used as part of an overall strategy with nutrition counseling, exercise counseling and integrating lower doses and modifying the dosing regimen? Yeah. But I don’t think most people need it if they understand how to change their hormones and their brain chemistry and their biology without that.”
Dr. Hyman also highlighted potential side effects of long-term use, noting that after four years of treatment, “your risk of bowel obstruction goes up by four and a half fold” and “risk of pancreatitis goes up by 900%.”
This clip outlines the importance of viewing medications like Ozempic as tools within a broader health strategy rather than standalone solutions for weight management. Dr. Hyman’s perspective suggests that healthcare providers should ensure patients receiving these medications also receive proper guidance on nutrition and exercise to maintain muscle mass and establish healthy habits for long-term success.
